Health insurance; authorization of drug prescribed for the treatment of a mental disorder. (SB1269)
Introduced By
Sen. Jeremy McPike (D-Dale City)
Progress
✓ |
Introduced |
☐ |
Passed Committee |
☐ |
Passed House |
☐ |
Passed Senate |
☐ |
Signed by Governor |
☐ |
Became Law |
Description
Health insurance; authorization of drug prescribed for the treatment of a mental disorder. Requires that any provider contract between a carrier and a participating health care provider with prescriptive authority, or its contracting agent, provide that no prior authorization is required for any drug prescribed for the treatment of a mental disorder listed in the most recent edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association if the prescription (i) is a covered benefit, (ii) does not exceed the U.S. Food and Drug Administration-labeled dosages, and (iii) has been continuously issued for no fewer than three months. The bill provides that this requirement does not prohibit a carrier from requiring step therapy for any drug that is not listed on its prescription drug formulary. Read the Bill »
Status
01/12/2021: Awaiting a Vote in the Commerce and Labor Committee
History
| Date | Action |
|---|---|
| 01/12/2021 | Prefiled and ordered printed; offered 01/13/21 21101311D |
| 01/12/2021 | Referred to Committee on Commerce and Labor |
| 01/18/2021 | Impact statement from DPB (SB1269) |
Post a Public Comment About this Bill